Pathophysiological mechanisms of central neuropathic pain after spinal cord injury

Spinal Cord

Volumn 36, Issue 9, 1998, Pages 601-612

  Eide, P K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Central neuropathic pain; Pathophysiology; Spinal cord injury; Therapy

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ; GLUTAMINE; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE AGONIST; SODIUM CHANNEL;

ABDOMINAL PAIN; HUMAN; HYPERACTIVITY; INHIBITORY POSTSYNAPTIC POTENTIAL; MONOAMINE NERVE CELL; NERVE POTENTIAL; NEUROCHEMISTRY; NEUROPATHIC JOINT DISEASE; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; SPINAL CORD INJURY; SPINOTHALAMIC TRACT; SYNAPTIC TRANSMISSION;

EID: 0031664003     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100737     Document Type: Review

References (93)

1. Bonica JJ. Introduction: Semantic, epidemiologic, and educational issues. In: Casey KL (ed). Pain and Central Nervous System Disease: The Central Pain Syndromes. Raven Press: New York 1991, pp 13-29.
2. Levi R, Hulting C, Nash MS, Seiger Å. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia 1995; 33: 308-315.
3. Stòrmer S et al. Chronic pain dysaesthesiae in spinal cord injury patients: Results of a multicentre study. Spinal Cord 1997; 35: 446-455.
4. Davis L, Martin J. Studies upon spinal cord injuries. II. Nature and treatment of pain. J Neurosurg 1947; 4: 483-491.
5. Donovan WH, Dimitrijevic MR, Dahm L, Dimitrijevic M. Neurophysiological approaches to chronic pain following spinal cord injury. Paraplegia 1982; 20: 135-146.
6. Beric A, Dimitrijevic MR, Lindblom U. Central dysesthesia syndrome in spinal cord injury patients. Pain 1988; 34: 109-116.
7. Beric A. Post-spinal cord injury pain states. Pain 1997; 72: 295-298.
8. Davidoff G, Roth EJ. Clinical characteristics of central (dysesthetic) pain in spinal cord injury patients. In: Casey KL (ed). Pain and Central Nervous System Disease: The Central Pain Syndromes. Raven Press: New York, 1991, pp 77-83.
9. Siddall PJ, Taylor DA, Cousins MJ. Classification of pain following spinal cord injury. Spinal Cord 1997; 35: 69-75.
10. Merskey H, Bogduk N (eds). Classification of Chronic Pain. IASP Press, Seattle 1994.
11. Meyer RA, Campbell JN, Raja SN. Peripheral neural mechanisms of nociception. In: Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 13-44.
12. Dubner R, Basbaum AI. Spinal dorsal horn plasticity following tissue or nerve injury. In: Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 225-241.
13. Boivie J. Central pain. In: Wall PD, Melzack RM (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 871-902.
14. Davidoff G et al. Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: A randomized, double-blind, placebo-controlled study. Pain 1987; 29: 151-161.
15. Drewes AM, Andreasen A, Pulsen LH. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia 1994; 32: 565-569.
16. Tasker RR, DeCarvalho GTC, Dolan EJ. Intractable pain of spinal cord origin: Clinical features and implications for surgery. J Neurosurg 1992; 77: 373-378.
17. Young RF. Clinical experience with radiofrequency and laser DREZ lesions. J Neurosurg 1990; 72: 715-720.
18. Pagni CA. Central pain due to spinal cord and brain stem damage. In: Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1989, pp 634-655.
19. Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery 1997; 40: 736-747.
20. Willis Jr WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord. Plenum Press: New York, 1991.
21. Verdugo R, Ochoa JL: Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. Brain 1992; 115: 893-913.
22. Ma W, Peschanski M, Ralstone III HJ. The differential synaptic organization of the spinal and lemniscal projections to the ventrobasal complex of the rat thalamus. Evidence for convergence of the two systems upon single thalamic neurons. Neuroscience 1987; 22: 925-934.
23. Eide PK, Jorum E, Stenehjem AE. Somatosensory findings in patients with spinal cord injury and central dysaesthcsia pain. J Neurol Neurosurg Psychiatry 1996; 60: 411-415.
24. Eide PK et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-354.
25. Eide PK, Stubhaug A. Relief of trigeminal neuralgia after percutaneous retrogasserian glycerol rhizolysis is dependent on normalization of abnormal temporal summation of pain without general impairment of sensory perception. Neurosurgery In press.
26. Price DD. Psychophysical measurement of normal and abnormal pain processing. In: Boivie J, Hansson P, Lindblom U (ed). Touch, Temperature, and Pain in Health and Disease: Mechanisms and Assessments, Progress in Pain Research and Management. Vol 3. IASP Press: Seattle, 1994, pp 3-25.
27. Bennett GJ. Neuropathic pain. In: Wall PD, Melzack RM (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 201-224.
28. Palecek J et al. Responses of spinothalamic tract cells to mechanical and thermal stimulation of skin in rats with experimental peripheral neuropathy. J Neurophysiol 1992; 67: 1562-1571.
29. Palecek J et al. Responses of spinothalamic tract neurons to mechanical and thermal stimuli in an experimental model of peripheral neuropathy in primates. J Neurophysiol 1992; 68: 1951-1966.
30. Guilbaud G, Benoist JM, Jazat F, Gautron M. Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy. J Neurophysiol 1990; 64: 1537-1554.
31. Albe-Fessard D, Rampin O. Neurophysiological studies in rats deafferenled by dorsal root sections. In: Nashold BS, Ovelmen-Levitt J (eds). Deafferentation Pain Syndromes: Pathophysiology and Treatment. Raven Press: New York, 1991, pp 125-139.
32. Yamashiro K et al. Neurons with high-frequency discharge in the central nervous system in chronic pain. Stereotactic Funct Neurosurg 1994; 62: 290-294.
33. Loeser JD, Ward AA. Some effects of deafferentation on neurons of the cat spinal cord. Arch Neurol 1967; 17: 629-636.
34. Koyama S et al. Thalamic neuronal hyperactivity following transection of the spinothalamic tract in the cat: Involvement of N-methyl-D-aspartate receptor. Brain Research 1993; 612: 345-350.
35. Hao JX et al. Transient spinal cord ischemia induces temporary hypersensitivity of dorsal horn wide dynamic range neurons to myelinated, but not unmyelinated, fiber input. J Neurophysiol 1992; 68: 384-391.
36. Yezierski RP, Park SH. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci Lett 1993; 157: 115-119.
37. Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 79-100.
38. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. exp Neurol 1996; 16: 316-332.
39. Price DD, Hull CD, Buckwald NA. Intracellular responses of dorsal horn cells to cutaneous and sural nerve A and C fiber stimuli. Exp Neurol 1971; 33: 291-309.
40. Price DD, Hayes RL, Ruda MA, Dubner R. Spinal and temporal transformations of input to spinothalamic tract neurons and their relation to somatic sensation. J Neurophysiol 1978; 41: 933-947.
41. Loeser JD, Ward AA, White LE. Chronic deafferentation of human spinal cord neurons. J Neurosurg 1968; 29: 48-50.
42. Edgar RE, Best LG, Quail PA, Obert AD. Computer-assisted DREZ microcoagulation: Posttraumatic spinal deafferentation pain. J Spinal Disord 1993; 6: 48-56.
43. Lenz FA et al. Abnormal single-unit activity and response to stimulation in the presumed ventrocaudal nucleus of patients with central pain. In: Dubner R, Gebhart GF, Bond MR (eds). Proceedings of the Vth World Congress on Pain. Elsevier Science Publishers BV, 1988, pp 157-164.
44. Lenz FA et al. Characteristics of somatotopic organisation and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection. J Neurophysiol 1994; 72: 1570-1587.
45. Yamashiro K et al. Neurones with epiletiform discharge in the central nervous system and chronic pain. Experimental and clinical investigations. Acta Neurochir 1991; 52: 130-132.
46. Rinaldi PC, Young RF, Albe-Fessard D, Chodakiewitz J. Spontaneous neuronal hyperaclivily in the medial and intralaminar thalamic nuclei of patients with deafferentation pain. J Neurosurg 1991; 74: 415-421.
47. Jeanmonod D, Magnin M, Morel A. Thalamus and neurogenic pain: Physiological, anatomical and clinical data. NeuroReport 1993; 4: 475-478.
48. Jeanmonod D, Magnin M, Morel A. Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain 1996; 119: 363-375.
49. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain 1993; 52: 259-285.
50. Fields HL, Rowbotham MC, Devor M. Excitability blockers: Anticonvulsants and low concentration local anesthetics in the treatment of chronic pain. In: Dickenson A, Besson J-M (eds). The Pharmacology of Pain. Springer Verlag: Berlin, 1997, pp 93-116.
51. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992; 48: 261-268.
52. Omana-Zapata I et al. Tetrodoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain 1997; 72: 41-49.
53. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996; 66: 69-77.
54. Awerbuch GI, Sandyk R: Mexiletine for thalamic pain syndrome. Intern J Neurosci 1990; 55: 129-133.
55. Hao JX et al. Allodynia-like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation. Pain 1991; 45: 175-185.
56. Hao JX, Yu YX, Seiger Å. Wiesenfeld-Hallin Z. Systemic tocainide relieves mechanical hypersensitivity and normalizes the responses of hyperexcitable dorsal horn wide-dynamic-range neurons after transient spinal cord ischemia in rats. Exp Brain Res 1992; 91: 229-235.
57. Xu XJ et al. Systemic mexiletine relieves chronic allodynialike symptoms in rats with ischemic spinal cord injury. Anesth Analg 1992; 74: 649-652.
58. Glynn CJ et al. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1986; II: 1249-1250.
59. Chiou-Tan FY et al. Effects of mexiletine on spinal cord injury dysesthetic pain. Am J Physical Med Rehabil 1996; 75: 84-87.
60. Higa K, Hirata K, Dan K. Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction. Pain 1997; 73: 97-99.
61. Bliss TVP, Collingridge GL. A synaptic model of memory: Long term potentiation in the hippocampus. Nature 1993; 361: 31-39.
62. Meldrum BS. Excitatory amino acid antagonists. Blackwell Scientific Publications: Oxford, 1991.
63. Dougherty PM, Palecek J, Zorn S, Willis WD. Combined application of excitatory amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons. Brain Res Rev 1993; 18: 227-246.
64. Carlton SM, Rees H, Gondesen K, Willis WD. Dextrorphan attenuates responses of spinothalamic tract cells in normal and nerve-injured monkeys. Neurosci Lett 1997; 229: 169-172.
65. Xu XJ, Hao JX, Seiger Å, Wiesenfeld-Hallin Z. Systemic excitatory amino acid receptor antagonists of the α-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats. J Pharm Exp Ther 1993; 267: 140-144.
66. Hao JX, Xu XJ. Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered excitatory amino acid receptor antagonists. Pain 1996; 66: 279-285.
67. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995; 37: 1080-1087.
68. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res 1987; 424: 402-406.
69. Salt TE, Wilson DG, Prasad SK. Antagonism of N-methylas-partate and synaptic responses of neurones in the rat ventrobasal thalamus by ketamine and MK-801. Br J Pharmacol 1988; 94: 443-448.
70. Thomson AM, West DC, Lodge D. An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: A site of action of ketamine? Nature 1985; 313: 479-481.
71. Wong CS et al. Ketamine potentiates morphine analgesic effect in postoperative epidural pain control. Abstracts of the 7th World Congress on Pain, Paris, 1993, p 136.
72. Eide PK, Stubhaug A, Øye I. The NMDA-antagonist ketamine for prevention and treatment of acute and chronic post-operative pain. Bailière's Clinical Anaesthesiology 1995; 9: 539-554.
73. Stubhaug A et al. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997; 41: 1124-1132.
74. Seltzer Z, Cohn S, Ginzburg R, Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 1991; 45: 69-75.
75. Hao JX et al. The excitatory amino acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the rat. Exp Neurol 1991; 113: 182-191.
76. Hao JX et al. Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia; implications for a tonic GABAergic inhibitory control of myelinated fiber input. J Neurophysiol 1992; 68: 392-396.
77. Zhang AL et al. Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res 1994; 656: 187-190.
78. Xu XJ et al. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: A possible animal model for pain in patients with spinal cord injury. Pain 1992; 48: 279-290.
79. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions: A pilot study. Clin J Pain 1992; 8: 338-345.
80. Taira T et al. A new approach to control central deafferentation pain: Spinal intrathecal baclofen. Stereotact Funct Neurosurg 1995; 65 101-105.
81. Loubser PG, Akman NM. Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 1996; 12: 241-247.
82. Ossipov MH, Malan Jr TP, Lai J, Porreca H. Opioid pharmacology of acute and chronic pain. In: Dickenson A, Besson J-M (eds). The Pharmacology of Pain. Springer Verlag: Berlin, 1997, pp 305-333.
83. Arnér S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11-23.
84. Xu XJ et al. Chronic pain-related behaviors in spinally injured rats: Evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain 1994; 56: 271-277.
85. Yu W, Hao JX, Xu XJ, Wiesenfeld-Hallin Z. Comparison of the anti-allodynic and antinociceptive effects of systemic, intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain. Eur J Pain 1997; 1: 17-29.
86. Yu W et al. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain 1998; 74: 115-122.
87. Laughlin TM et al. Spinally administered dynorphine A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors. Pain 1997; 72: 253-260.
88. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone: Edinburgh, 1994, pp 243-257.
89. Eide PK, Hole K: The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993; 13: 75-85.
90. Eide PK, Rosland JH. The role of tail skin temperature in the facilitation of the tail-flick reflex after spinal transection or interference with descending serotonergic neurotransmission. Acta Physiol Scand 1989; 135: 427-433.
91. 1 receptor agonist after lesion of raphe-spinal serotonergic neurones. Pharmacol Toxicol 1992; 71: 62-64.
92. Hao JX, Yu W, Xu XJ, Wiesenfeld-Hallin Z. Effects of intrathecal vs. systemic clonidine in treating chronic allodynia-like response in spinally injured rats. Brain Res 1996; 736: 28-34.
93. Siddall PJ, Gray M, Rutkowski S, Cousins MJ. Intrathecal morphine and clonidine in the management of spinal cord injury pain: A case report. Pain 1994; 59: 147-148.